Sign Up Today and Learn More About China Resources Pharmaceutical Group Stock
Invest in or calculate the value of your shares in China Resources Pharmaceutical Group or other pre-IPO companies through EquityZen's platform.
China Resources Pharmaceutical Group Stock (CRPG)
CR Pharma engages in the research and development, manufacturing, distribution, and retail of pharmaceutical and healthcare products.
About China Resources Pharmaceutical Group Stock
Founded
2007
Industries
Software, Artificial Intelligence, Data and Analytics
China Resources Pharmaceutical Group Press Mentions
Stay in the know about the latest news on China Resources Pharmaceutical Group
Chinese firms to repurpose cancer drug for Alzheimer’s
thepharmaletter • Jan 15, 2025
Key Driver Transforming Small Molecule Active Pharmaceutical Ingredient Market 2024: Adoption Of Personalized Medicine
einpresswire • Nov 22, 2024
China Resources Pharmaceutical Group (HKG:3320) Is Increasing Its Dividend To CNÂĄ0.1697
simplywall • Apr 24, 2024
Jia Yuan assists CR Pharma's RMB6.2bn mixed-ownership reform
law • Apr 24, 2024
PRESS RELEASE: A New Generation of Probiotic Products Launching Across China – Media Database
getthewordout • Apr 24, 2024
China Resources Pharmaceutical Group Management
Leadership team at China Resources Pharmaceutical Group
Senior Vice President
Jun Wu
CEO
Chuncheng Wang
Join now and verify your accreditation status to gain access to:
- China Resources Pharmaceutical Group Current Valuation
- China Resources Pharmaceutical Group Stock Price
- China Resources Pharmaceutical Group Management
- Available deals in China Resources Pharmaceutical Group and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- China Resources Pharmaceutical Group Cap Table and Funding History by Share Class and Liquidity Preferences
- China Resources Pharmaceutical Group Revenue and Financials
- China Resources Pharmaceutical Group Highlights
- China Resources Pharmaceutical Group Business Model
- China Resources Pharmaceutical Group Risk Factors
- China Resources Pharmaceutical Group Research Report from SACRA Research
Trading China Resources Pharmaceutical Group Stock
How to invest in China Resources Pharmaceutical Group stock?
Accredited investors can buy pre-IPO stock in companies like China Resources Pharmaceutical Group through EquityZen funds. These investments are made available by existing China Resources Pharmaceutical Group shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell China Resources Pharmaceutical Group stock?
Shareholders can sell their China Resources Pharmaceutical Group stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
